EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

RecruitingOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

June 7, 2024

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

ctDNA MRD test

Blood and tissue samples will be collected for the ctDNA MRD test

Trial Locations (44)

11794

RECRUITING

Stony Brook Medicine, Stony Brook

15213

RECRUITING

UPMC Magee - Womens Hospital, Pittsburgh

17033

RECRUITING

Penn State Cancer Institute, Hershey

17111

RECRUITING

Penn State Health Medical Group - Andrews Patel, Harrisburg

20818

RECRUITING

The Center for Cancer and Blood Disorders - Bethesda, Bethesda

20910

RECRUITING

Holy Cross Hospital - Silver Spring, Silver Spring

21061

RECRUITING

Tate Cancer Center at UM Baltimore Washington, Glen Burnie

21204

RECRUITING

Greater Baltimore Medical Center, Baltimore

RECRUITING

University of Maryland St. Joseph Medical Center, Towson

21215

RECRUITING

Sinai Hospital of Baltimore, Baltimore

21237

RECRUITING

MedStar Georgetown Cancer Institute, Baltimore

23114

RECRUITING

Bon Secours Cancer Institute at St. Francis, Midlothian

23298

RECRUITING

VCU Massey Comprehensive Cancer Center, Richmond

26505

RECRUITING

WVU Cancer Institute, Morgantown

27804

RECRUITING

UNC Cancer Care at Nash, Rocky Mount

28204

RECRUITING

Atrium Health Levine Cancer Institute, Charlotte

28374

RECRUITING

FirstHealth Outpatient Cancer Center, Pinehurst

32701

RECRUITING

AdventHealth East Altamonte Oncology and Hematology, Altamonte Springs

33140

RECRUITING

Mount Sinai Medical - Comprehensive Cancer Center, Miami Beach

33324

RECRUITING

Baptist Cancer Care - Plantation, Plantation

33607

RECRUITING

St. Joseph's Women's Hospital, Tampa

37660

RECRUITING

Ballad Health Cancer Center, Kingsport

40202

RECRUITING

Norton Cancer Institute - Downtown, Louisville

40207

RECRUITING

Baptist Health Louisville, Louisville

41017

RECRUITING

St. Elizabeth Edgewood Hospital, Edgewood

44195

RECRUITING

Cleveland Clinic Main Campus, Cleveland

44710

RECRUITING

Aultman Timken Family Cancer Center, Canton

53226

RECRUITING

Aurora Cancer Care - Wauwatosa, Wauwatosa

55426

RECRUITING

Metro Minnesota Community Oncology Consortium (MMCORC), Saint Louis Park

57105

RECRUITING

Avera Cancer Institute, Sioux Falls

60607

RECRUITING

Rush Cancer Center, Chicago

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

79410

RECRUITING

Joe Arrington Cancer Research & Treatment Center, Lubbock

94304

RECRUITING

Stanford Cancer Institute, Palo Alto

94589

RECRUITING

Kaiser Permanente Medical Center, Vallejo

99508

RECRUITING

Katmai Oncology Group - Anchorage, Anchorage

01805

RECRUITING

Lahey Hospital & Medical Center, Burlington

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

02905

RECRUITING

Women & Infants Hospital, Providence

H1T 2M4

RECRUITING

Maisonneuve-Rosemont Hospital (HMR), Montreal

H2X 3E4

RECRUITING

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

H3T1E2

RECRUITING

Jewish General Hospital, Montreal

Unknown

RECRUITING

McGill University Health - Glen Site, Montreal

G1S 4L8

RECRUITING

Hôpital du Saint-Sacrement, Québec

Sponsors
All Listed Sponsors
collaborator

NSABP Foundation Inc

NETWORK

lead

Exact Sciences Corporation

INDUSTRY

NCT06401421 - EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) | Biotech Hunter | Biotech Hunter